New BNT162b2 XBB Vaccine Provides Significant Additional Protection Against COVID-19 Hospitalization and ED Visits: Study Dr Riya Dave9 July 2024 8:45 PM ISTResearchers have found that the recently recommended BNT162b2 XBB vaccine (Pfizer-BioNTech; 2023-2024 formulation) offers substantial additional...
Study Affirms Safety: First-Trimester mRNA COVID-19 Vaccination Shows No Link to Structural Birth Defects Medha Baranwal4 July 2024 8:45 PM ISTUSA: Recent research examining the safety of COVID-19 vaccination during the first trimester of pregnancy has provided reassuring findings regarding...
Vaccination may reduce risk of cognitive impairment in patients with COVID 19 infections: Study Dr. Kamal Kant Kohli1 July 2024 4:45 AM ISTSince the outset of the COVID 19 pandemic, 10 to 30 per cent of the general population has experienced some form of virus-induced cognitive...
Case Report of Management of TAFRO Syndrome after Vaccination with Cyclosporine Treatment Medha Baranwal28 Jun 2024 10:30 PM ISTJapan: In a rare medical occurrence shedding light on potential post-vaccination complications, a case of TAFRO syndrome has been reported, marking a...
Study Finds Patient-Reported Link Between COVID-19 and its vaccination with Allergic Contact Dermatitis Medha Baranwal18 Jun 2024 7:00 AM ISTUSA: In a recent study published in Dermatitis Journal, researchers have uncovered a potential association between COVID-19 infection or vaccination...
USFDA approves Alembic Pharma Icatibant Injection for acute attacks of hereditary angioedema Ruchika Sharma17 Jun 2024 3:29 PM ISTIcatibant injection is indicated for the treatment of acute attacks of hereditary angioedema in adults 18 years of age and older.
Birth by C-section more than doubles odds of measles vaccine failure, claims study Dr. Kamal Kant Kohli4 Jun 2024 8:30 PM ISTA study by the University of Cambridge, UK, and Fudan University, China, has found that a single dose of the measles jab is up to 2.6 times more...
HPV vaccine prevents most cervical cancer cases in more deprived groups, major study shows Dr. Kamal Kant Kohli2 Jun 2024 8:45 PM ISTThe human papillomavirus, or HPV, vaccine is cutting cases of cervical cancer right across the socio-economic spectrum, with most cases being...
COVID boosters targeting omicron subvariants of SARS-CoV-2 less protective against the now-dominant JN.1 strain: Study Dr. Kamal Kant Kohli31 May 2024 9:00 AM ISTBoosters that target the omicron subvariants of SARS-CoV-2 are still providing reasonably durable protection against infection, hospitalization and...
High-Dose Influenza Vaccine Reduces Hospitalization in Seniors, claims study Dr Riya Dave27 May 2024 10:00 AM ISTResearchers have found that high-dose influenza vaccine (HD-IV) significantly reduces the rates of pneumonia and influenza (P&I) and all-cause...
ICMR junks BHU's Covaxin Safety study, criticizes it for Poor Methodology and Design Kajal Rajput20 May 2024 3:42 PM ISTNew Delhi: The apex research regulator, the Indian Council of Medical Research (ICMR) has distanced itself from the study, published by the Banaras...
COVID vaccine: Moderna wins patent case in Europe against Pfizer, BioNTech Ruchika Sharma19 May 2024 1:00 PM ISTLondon: Moderna announced on Friday that it has emerged victorious in a case at the European Patent Office against Pfizer and BioNTech concerning...
